ABSTRACT Background: The pathogenesis of diarrhea in patients receiving enteral feeding includes colonic water secretion, antibiotic prescription, and enteropathogenic colonization, each of which involves an interaction with the gastrointestinal microbiota. Objective: The objective was to investigate temporal changes in the concentrations of fecal microbiota and short-chain fatty acids (SCFAs) in patients starting 14-d of enteral feeding and to compare these changes between patients who do and do not develop diarrhea. Design: Twenty patients starting exclusive nasogastric enteral feeding were monitored for 14 d. Fecal samples were collected at the start, middle, and end of this period and were analyzed for major bacterial groups by using culture independent fluorescence in situ hybridization and for SCFAs by using gas-liquid chromatography. Results: Although no significant changes in fecal microbiota or SCFAs were observed during enteral feeding, stark alterations occurred within individual patients. Ten patients (50%) developed diarrhea, and these patients had significantly higher concentrations of clostridia (P ¼ 0.026) and lower concentrations (P ¼ 0.069) and proportions (P ¼ 0.029) of bifidobacteria. Patients with and without diarrhea had differences in the proportion of bifidobacteria (median: 0.4% and 3.7%; interquartile range: 0.8 compared with 4.3; P ¼ 0.035) and clostridia (median: 10.4% and 3.7%; interquartile range: 14.7 compared with 7.0; P ¼ 0.063), respectively, even at the start of enteral feeding. Patients who developed diarrhea had higher concentrations of total fecal SCFAs (P ¼ 0.044), acetate (P ¼ 0.029), and butyrate (P ¼ 0.055). Conclusion: Intestinal dysbiosis occurs in patients who develop diarrhea during enteral feeding and may be involved in its pathogenesis.
INTRODUCTION
Enteral feeding is a common method of nutritional support for patients unable to achieve their nutritional requirements through oral diet alone. However, diarrhea is a potential consequence that has been reported in 2-95% of patients (1, 2) or on 2-26% of patient days (3) . Diarrhea during enteral feeding may result in many problematic complications, including fluid and electrolyte abnormalities (4), fecal incontinence (5) , and burdens for the patient and their nurse or caregiver (6) .
The pathogenesis of diarrhea is multifactorial. Intragastric enteral feeding results in an abnormal secretion of water into the ascending colon (7) . Meanwhile, the incidence of diarrhea is higher in those who are prescribed antibiotics (8) , and enteral feeding is associated with an increased risk of Clostridium difficile-associated diarrhea (CDAD) (9) . Each of these mechanisms involves an interaction with the gastrointestinal (GI) microbiota. For example, the microbiota may prevent infection through pathogen inhibition (10) and they ferment carbohydrates and proteins to produce short-chain fatty acids (SCFAs) that stimulate colonic water absorption (11) . Meanwhile, antibiotics result in major alterations to both the microbiota (12) and SCFAs (13) .
The GI microbiota is a highly complex and diverse microbial ecosystem consisting of .500 species of bacteria (14) . Investigating their role in clinical nutrition has been impeded by the subjective limitations of bacterial culture for their analysis. However, nucleotide probes targeting the 16S rRNA of specific bacterial groups (14) have enabled identification of alterations in the luminal microbiota in inflammatory bowel disease (15) and CDAD (16) .
Despite their potential role in the pathogenesis of diarrhea, few studies have used genotypic techniques to investigate the GI microbiota during enteral feeding (17) . One study showed that enteral formula results in major reductions in total fecal bacteria in healthy subjects (18) , whereas low concentrations of bifidobacteria were found in patients receiving short-term (19) and long-term (20) enteral feeding.
It is unclear whether such alterations in the GI microbiota are associated with diarrhea in patients receiving enteral feeding. Therefore, through collection and analysis of serial samples, the aim of this study was to investigate temporal changes in the concentrations of fecal microbiota and SCFAs in patients starting 14-d of enteral feeding and to compare these changes between those who did and did not subsequently develop diarrhea.
SUBJECTS AND METHODS

Patients
Patients starting exclusive nasogastric enteral feeding with standard, fiber-free formula were recruited from St George's Hospital, London, United Kingdom. To reduce the diversity in the patient population recruited, the exclusion criteria included patients in the intensive care unit, who may have been receiving numerous diverse antibiotics atvarious doses. Other exclusion criteriaincluded those who had received fiber, probiotic, or prebiotic supplements withinthe previousmonthandthosewithaGIdisorderlikelytoresult in altered microbiota or SCFAs (eg, irritable bowel syndrome, inflammatory bowel disease, and previous GI surgery).
The study was approved by the Local Research Ethics Committees of King's College London and the Merton, Sutton, and Wandsworth Health Authority. Before recruitment to the study, informed consent was obtained from the patient or from their next of kin and the medical team if unconscious at the time that assent was obtained.
Study design
In this prospective observational study, patients received enteral feeding via a nasogastric tube as clinically indicated. The volume of formula prescribed was based on each patient's total energy expenditure, which was calculated by adjusting basal metabolic rate [calculated by using modified Schofield equations (21) ] for physical activity and disease (22) . The energy contents of the formulas were 1.0 kcal/mL (Osmolite; Abbott UK, Maidenhead, Berks, United Kingdom), 1.2 kcal/mL (Osmolite Plus; Abbott UK), or 1.5 kcal/mL (Ensure Plus; Abbott UK), depending on each patient's calculated expenditure. Formula was delivered through a nasogastric tube via a pump infusion starting at a rate of 25 mL/h and increasing by 25 mL/h every 4 h until the full feeding rate was achieved (range:75-125 mL/h).
For the purposes of this study, patients were monitored for 14 d from passage of the first fecal sample after initiation of enteral feeding. Fecal output was recorded by nursing staff using a stool chart validated for use in this patient group (23) . The chart facilitates accurate characterization of fecal frequency, consistency, and weight, which are then summarized into a daily stool score whereby a score of !15 is used to indicate diarrhea. Wards were visited 3 times/d on weekdays and were contacted by telephone on weekends to monitor data recording by the nursing staff. Demographic data (eg, age and sex) and clinical details were obtained from the patients' medical notes, which were also monitored daily to obtain information on antibiotic prescription.
Whenever possible, a fecal sample was collected for analysis on days 1, 7, and 14. To ensure accurate measurement of microbiota and SCFAs, only fresh fecal samples were analyzed. However, in the absence of habitual or meal cues to stool output (24) , feces were sometimes not voided on these days or were voided during the night, which precluded their use. Samples were therefore collected and analyzed from each patient during 4-d periods at the start (days 1-4), middle (days 6-9), and end (days [11] [12] [13] [14] of the 14 d of enteral feeding.
Fecal microbiology
Fecal samples were collected within 1 h of voiding and were immediately transported to the laboratory for analysis of microbiota, SCFAs, pH, and C. difficile enterotoxins. Predominant components of the fecal microbiota were quantified by using fluorescent in situ hybridization (25) . Briefly, fecal bacteria were harvested in phosphate-buffered saline (0.1 mol/L; pH 7Á0) with the use of a stomacher and were then fixed overnight in 4% (wt:vol) paraformaldehyde. Bacteria were then washed and suspended in a 1:1 solution of phosphate-buffered saline and 96% (vol:vol) ethanol and stored at 220°C until hybridization. Total bacteria were enumerated by using the nucleic acid stain 4,6-diamidino-2-phenylindole for total cell counts (26) . Meanwhile, individual species were enumerated through hybridization with oligonucleotide probes targeting specific regions of 16S rRNA ( Table 1 ). In the absence of a probe targeting all clostridia, probes were used that would target C. lituseburense (cluster XI, including C. difficile), C. histolyticum (clusters I and II, including C. perfringens), and C. coccoides-E. rectale (cluster CIV). Probes were manufactured and labeled with the indocarbocyanin fluorescent marker Cy3. The bacteria were hybridized with the probe (4.5 ng/lL) in hybridization buffer (0.9 mol/L NaCl; 0.02 mol/L Tris/HCl; 0.01% wt:vol sodium dodecyl sulfate) and incubated overnight at the relevant temperature for that probe. The hybridization mix was then vacuum filtered, and the filter was mounted onto a microscope slide, which was then examined by using fluorescence microscopy on an Axioplan 2 microscope (Zeiss, Göttingen, Germany) equipped with an HBO-100 fluorescent lamp (Osram, Munich, Germany). Duplicate slides were enumerated manually through random selection of 15 fields. All hybridization and enumeration was conducted at the University of Reading by microbiologists blinded to all patient details, including whether the patient developed diarrhea.
Fecal SCFAs were analyzed by using gas-liquid chromatography. Samples were frozen at 280°C within 1 h of voiding and stored until analyzed. SCFAs were extracted in a buffer (1% wt:vol H 3 PO 4 ; 0.1% wt:vol HgCl 2 ) containing 2,2-dimethylbutyric acid as an internal standard. In duplicate, the extracted SCFAs were injected splitless into a Hewlett-Packard 6890 series gas-liquid chromatography system equipped with a 530-lm internal diameter and a 30-m fused silica capillary column with a film thickness of 1 lm (J&W Scientific, Koeniz, Switzerland). The initial oven temperature was 80°C, which increased by 10°C/min until 145°C and then to 100°C/min until 200°C to ensure complete elution. All chromatograms were automatically integrated on a Hewlett-Packard Chemstation.
Fecal bacteria and SCFA concentrations were expressed per gram of dry feces to standardize comparisons between samples with different water contents. Fecal water content was determined by measuring the weight loss of a 3-5-g sample after lyophilization. Duplicate preweighed samples were dried at 245°C in a lyophilizer for !7 d until constant weight was recorded. Fecal pH was measured with a pH electrode and meter. Fresh fecal samples were diluted with buffer and homogenized in a stomacher; pH was measured by using an epoxy electrode designed for use in slurries (pHASE, BDH, London, United Kingdom), which was attached to a portable meter accurate to a pH of 0.01 (Hartman, London, United Kingdom).
C. difficile-enterotoxins A and B were detected with an enzymelinked immunosorbent assay kit (ToxA/B II; TechLab, Blacksburg, VA) according to the manufacturer's instructions. A diagnosis of CDAD was given when a patient had diarrhea (stool score of !15) in conjunction with a positive enterotoxin test.
Statistical analysis
All data were analyzed by using SPSS for Windows (version 14.0; SPSS Inc, Chicago, IL). Data are presented as means 6 SDs or medians (interquartile ranges; IQR) as indicated. A P value , 0.05 was considered statistically significant. Bacterial numbers were log transformed. Baseline samples were compared between age ( 75 y or .75 y), antibiotic prescription (yes or no), and diarrhea (yes or no) by using a Mann-Whitney test. A repeated-measures analysis of variance was conducted on data for fecal microbiota, SCFAs, and pH across the 3 time points (start, middle, and end). A within-subject factor analysis was used to investigate the effect of time, and a between-subject factor analysis was used to investigate the effect of age ( 75 y or .75 y), antibiotic prescription (yes or no), or diarrhea (yes or no) on these variables. Interactions between each of these variables and time were also investigated. Because of inadequate samples for analysis of SCFAs and pH at all 3 time points, mean values were calculated from each patient's pooled values across the 14-d period of enteral feeding. These mean values were then used to calculate the median and IQR for all 20 patients and for the 2 groups (no diarrhea and diarrhea), which were compared by using a Mann-Whitney test.
RESULTS
Patient cohort
Thirty-six patients (12 men and 24 women) were recruited to the study; however, 16 were subsequently excluded because of introduction of oral diet (n ¼ 10), death (n ¼ 4), transfer to another hospital (n ¼ 1), or a decision to cease enteral feeding (n ¼ 1) before study completion. The remaining 20 patients (5 men and 15 women) were aged 77 y and 5 mo 6 10 y and 7 mo.
Indications for enteral feeding were the risk of aspiration secondary to acute stroke (n ¼ 15), muscular dystrophy (n ¼ 1), multiple sclerosis (n ¼ 1), tracheostomy placement (n ¼ 1), disease-related anorexia secondary to fractured pelvis (n ¼ 1), or pneumonia (n ¼ 1). The energy prescription was 1525 6 167 kcal/d. At baseline, the serum albumin concentration was 27.9 6 6.4g/L, whereas 17 (85%) patients had values ,35 g/L and 2 (10%) had values ,20 g/L.
Eleven patients were already receiving antibiotics when the first sample was collected and had been receiving such for 5.0 6 SD d. Five patients were subsequently prescribed antibiotics during the 14 d of enteral feeding. These 16 patients received 1 (n ¼ 3 patients), 2 (n ¼ 4), 3 (n ¼ 7), or 4 (n ¼ 2) different courses of antibiotics. The antibiotics included a range of penicillins, cephalosporins, and quinolones delivered enterally or parenterally. Only 4 patients did not receive antibiotics before or during the 14 d of enteral feeding.
Variability in microbiota and SCFAs
There were no within-subject changes in the concentration or proportion of any of the bacterial groups measured between the start, middle, and end of the 14 d of enteral feeding ( Table 2) . However, far from being stable, data from individual patients indicated that some had large reductions, some had large increases, and some had very stable microbiota (Figure 1) .
Analysis of SCFA concentrations and fecal pH at all 3 time points was only possible in 12 and 13 patients, respectively, because of insufficient samples at one of the time points in the remainder. In these patients, there were no significant withinsubject changes in the concentrations of any of the SCFAs or in fecal pH between the start, middle, and end of the 14-d enteral feeding period (Table 2 ). However, as for fecal bacteria, the raw data showed that individual patients had highly variable concentrations of SCFAs.
Microbiota, age, and antibiotics
The effect of age and antibiotics on microbiota, both at the start and across all 3 time points during enteral feeding, was investigated. In the first fecal sample collected, there was a trend toward lower numbers of bacteroides (median: 9.6; IQR: 1.4 compared with 10.3; 1.0 log 10 cells/g dry feces; P ¼ 0.054) and significantly lower Atopobium (median: 9.6; IQR: 1.0 compared with 10.1; 0.5 log 10 cells/g dry feces; P ¼ 0.007) in patients older than 75 y (n ¼ 12) compared with those 75 y or younger (n ¼ 8). However, there were no between-subject effects of age on the concentration or proportion of the microbiota between the start, middle, and end of the 14 d of enteral feeding (P values ranged from 0.1 to 0.841), nor were there any age or time interactions (P values ranged from 0.1 to 0.927).
In the first fecal sample collected, there were no significant differences in concentration or proportion of the microbiota between patients who were already receiving antibiotics (n ¼ 11) and those who were not (n ¼ 9) (P values ranged from 0.112 to 0.882). Interestingly, the fecal water content was greater in those who were already receiving antibiotics (median: 80.5%; IQR: 6.7) than in those who were not (70.9%; 15.5; P ¼ 0.02). Similarly, there were no significant differences in the concentration or proportion of microbiota between those who did (n ¼ 16) and did not (n ¼ 4) receive antibiotics at any time point during the 14-d enteral feeding period (P values ranged from 0.19 to 0.984; repeated-measures ANOVA). There was, however, an interaction between antibiotic use and time for the proportion of clostridia, which decreased across the 3 time points in those not receiving antibiotics (27.3%, 9.0%, and 4.5%) relative to the stable proportions in those receiving antibiotics (9.3%, 9.0%, and 11.3%) (P for interaction ¼ 0.043). There were no other antibiotic use or time interactions (P values ranged from 0.134 to 0.993).
Microbiota, SCFAs, and diarrhea
Ten patients (50%) experienced diarrhea at least once during the 14-d period, and its incidence was 14% of patient days. Four (20%) patients developed CDAD. The approaches to managing diarrhea included reducing or stopping antibiotics (n ¼ 3), reducing the volume of formula delivered (n ¼ 2) and, in those patients with CDAD, prescribing metronidazole (n ¼ 4).
In total, serum albumin was measured 63 times, and C-reactive protein was measured 103 times throughout the study. Although it was not a primary objective of the current study, the association between serum albumin and C-reactive protein and the fecal score was briefly evaluated. Interestingly, the fecal score negatively correlated with serum albumin concentrations (Pearson's correlation coefficient ¼ -0.363, P ¼ 0.003) and positively correlated with C-reactive protein (Pearson's correlation coefficient ¼ 0.264, P ¼ 0.007) for the days on which they were measured. However, because some patients were represented numerous times, data were also analyzed by using an analysis of covariance, which indicated that neither albumin (B value ¼ 0.146, P ¼ 0.698) nor C-reactive protein (B value ¼ 20.019, P value ¼ 0.184) was significantly associated with fecal score between patients.
The first fecal sample collected at the start of enteral feeding contained significantly lower proportions of bifidobacteria in those who subsequently developed diarrhea (n ¼ 10) than in those who did not (n ¼ 10), respectively (median: 0.4% compared with 3.7%; IQR: 0.8 compared with 4.3; P ¼ 0.035), and showed a trend toward higher proportions of clostridia in those who subsequently developed diarrhea (n ¼ 10) than in those who did not (n ¼ 10), respectively (median: 10.4% compared with 3.7%; IQR: 14.7 compared with 7.0; P ¼ 0.063).
When a comparison was made across all 3 time points, there were significantly higher concentrations of clostridia (P ¼ 0.026), lower proportions of bifidobacteria (P ¼ 0.029), and a trend to lower concentrations of bifidobacteria (P ¼ 0.069) and higher bacteroides-prevotella (P ¼ 0.07) in those who developed diarrhea than in those who did not develop diarrhea ( Table 2, Table 3 ). There were no significant diarrhea or time interactions in the concentration or proportion of microbiota (Table 2 ).
There were significantly higher concentrations of total fecal SCFA (P ¼ 0.044), acetate (P ¼ 0.029), and a trend toward higher concentrations of butyrate (P ¼ 0.055) in patients who developed diarrhea (n ¼ 5) compared with those who did not (n ¼ 7; Table 2, Table 3 ). There were no significant interactions between diarrhea and time for SCFA concentrations ( Table 2) .
Of the 16 patients who received antibiotics, 9 (56%) developed diarrhea, whereas only 1 of those who did not receive antibiotics (25%) developed diarrhea (P ¼ 0.582). Of the 11 patients receiving antibiotics at baseline, 7 (64%) developed diarrhea and 4 (36%) did not. This group of 11 patients was analyzed independently, and no significant differences in microbiota between those who did and did not develop diarrhea were detected in the baseline sample or across all 3 time points. 1 P values reflect within-subject effects of time (repeated-measures ANOVA).
2 P values reflect between-subject effects of diarrhea (repeated-measures ANOVA).
P values reflect interactions between time and diarrhea (repeated-measures ANOVA).
4 P values relate to within-subject effects of time and between-subject effects of diarrhea after a comparison of those patients who did (n ¼ 10) and did not (n ¼ 10) develop diarrhea (repeated-measures ANOVA).
5 Mean 6 SD (all such values).
6 P values relate to within-subject effects of time and between-subject effects of diarrhea after a comparison of those patients who did (n ¼ 7) and did not (n ¼ 5) develop diarrhea (repeated-measures ANOVA).
7 P values relate to within-subject effects of time and between-subject effects of diarrhea after a comparison of those patients who did (n ¼ 7) and did not (n ¼ 6) develop diarrhea (repeated-measures ANOVA).
Individual values for microbiota, SCFAs, and fecal pH at the start, middle, and end of enteral feeding were pooled for each of the 20 patients, allowing inclusion of data from those who had insufficient sample for analysis of SCFAs and pH at all 3 time points. There were significantly higher concentrations (P ¼ 0.019) and proportions (P ¼ 0.041) of clostridia, higher proportions of bacteroides (P ¼ 0.041), and higher concentrations of total SCFAs (P ¼ 0.009) and acetate (P ¼ 0.002) in patients with diarrhea (Table 4) .
Interestingly, when patients were categorized into those without diarrhea (n ¼ 10), those with CDAD (n ¼ 4), and those with enteral feeding-associated diarrhea (diarrhea without CDAD; n ¼ 6), there remained significantly higher concentrations of clostridia in patients with enteral feeding-associated diarrhea than in those without diarrhea (P ¼ 0.003, Mann-Whitney plus Bonferroni post hoc correction).
DISCUSSION
Enteropathogenic infection and colonic water secretion are involved in the pathogenesis of diarrhea in patients receiving enteral feeding. The GI microbiota play an important role in FIGURE 1. A-E: Concentration of bacteria measured by using fluorescence in situ hybridization at the start, middle, and end of 14 d of enteral feeding in 20 patients. The continuous black line represents mean 6 SD values. No significant within-subject effect of time over this period was observed for any of the bacteria measured. However, the gray lines, which represent data for each patient, indicate a dynamic microbial ecosystem. The continuous gray lines represent data for patients who did not develop diarrhea (n ¼ 10), and the dotted gray lines represent data for those who did develop diarrhea (n ¼ 10). The within-subject effects of time and between-subject effects of diarrhea were calculated by using repeated-measures ANOVA. No significant interactions between time and diarrhea were observed. preventing enteropathogenic infection, whereas the SCFAs they produce stimulate colonic water secretion. Despite the use of a relatively small sample of patients, this study showed that the fecal microbiota were highly variable and that significant differences existed between those that did and did not develop diarrhea.
At the start of the enteral feeding period, the concentration of total bacteria varied between patients by just over 10-fold, whereas for bifidobacteria it varied 1000-fold (Figure 1 ). This finding supports the view that the composition of the GI microbiota varies greatly between individuals.
The absence of a significant effect of time on the fecal microbiota was surprising, especially because enteral formula results in a reduction in fecal bacteria in healthy subjects over the same time period (18) . However, there were sometimes large within-subject changes in fecal microbiota that occurred, albeit in nonsystematic directions (Figure 1 ). This instability was also observed for SCFAs and has been shown previously (31) and is likely to be caused by the absence of fermentable carbohydrate in the formula (17) , the occurrence of pathological changes such as diarrhea (32) , and antibiotic use.
The absence of a difference in microbiota between those prescribed and those not prescribed antibiotics was likely due to the low numbers of patients not prescribed them (n ¼ 4), the variability in the timing, the route of delivery and the type of antibiotic prescribed (12) , and the wide interindividual response of the microbiota to antibiotics (33) . Antibiotics also have differential effects on fecal SCFAs. For example, vancomycin causes major reductions, erythromycin causes only moderate reductions, and doxycycline has no effect (34); each of these antibiotics were prescribed to at least one patient in the current study.
The current study was the first to use genotypic hybridization techniques to compare differences in the microbiota between a cohort of patients who did and did not develop diarrhea during enteral feeding. Those who developed diarrhea had higher fecal clostridia counts and a trend toward lower bifidobacteria counts. The latter may be the result, in part, of the use of antibiotics, such as amoxicillin, cefuroxime, erythromycin, and vancomycin (12) , which reduce fecal bifidobacteria and were each prescribed to at least one patient during this study. However, lower proportions of bifidobacteria existed even in the first sample collected at the start of the 14-d period of enteral feeding, before the patients developed diarrhea and before many of these antibiotics were prescribed. This may therefore indicate that diarrhea that developed during enteral feeding was partly due to prior dysbiosis and not to antibiotic use.
Diarrhea during enteral feeding involves various mechanisms and primary alterations in absorptive physiology. Despite the small numbers involved, higher clostridia counts persisted in the 6 patients with enteral feeding-associated diarrhea (diarrhea without CDAD). Although such a dysbiosis has been reported in patients with CDAD (16), it has not been previously reported in patients with enteral feeding-associated diarrhea. Aging may be another contributor, with evidence that older persons have lower bifidobacteria and bacteroides counts than do healthy young adults (16, 35) . Whether an association exists between aging and the risk of diarrhea during enteral feeding and whether this is mediated by GI dysbiosis warrants investigation. Bifidobacteria exert antimicrobial activity against many enteropathogens (36) , and their reduction in the present study may have impaired the ability of the GI microbiota to exert pathogen inhibition (10) , which increased the risk of colonization with enteropathogens such as C. difficile. Although this dysbiosis is likely to be involved in the pathogenesis of diarrhea, the nature of the study design was such that a causal relation could not be proven. However, a major strength of this prospective cohort study was that it allowed collection of serial samples from unselected patients before diarrhea developed.
Whether the correction of dysbiosis will prevent diarrhea is debatable. Probiotic lactobacilli have been shown to prevent antibiotic-associated diarrhea and CDAD in hospitalized inpatients not receiving enteral feeding (37), whereas 2 controlled trials found contrasting results of their effect on the incidence of diarrhea during enteral feeding (8, 38) . The results of the current study suggest that probiotic bifidobacteria may be a suitable candidate for future research. Prebiotic carbohydrates (eg, fructooligosaccharides) increase fecal bifidobacteria and reduce clostridia in healthy subjects (18) , although the same effect was not confirmed in patients receiving long-term enteral feeding (20) . To our knowledge, no controlled trials of the effects of prebiotics on diarrhea prevention in enteral feeding have been conducted (39) .
SCFAs stimulate colonic water absorption in patients receiving enteral feeding (11) . They have numerous other important roles, for example, colonocytes, the morphology and function of which may be impaired during malnutrition, use butyrate as a primary metabolic substrate (40) . However, patients who developed diarrhea actually had higher concentrations of fecal SCFAs. This was likely due to faster small intestinal transit times resulting in transient carbohydrate malabsorption, which thus increases the substrate available for colonic fermentation, which is compounded by faster colonic transit that would reduce SCFA absorption (41, 42) . Furthermore, exogenous and endogenous proteins undergo colonic fermentation, which results in production of ammonia and the branched-chain SCFAs isobutyrate and isovalerate (43) . Therefore, the maintenance of neutral fecal pH despite elevated concentrations of SCFAs in those with diarrhea may be the result, in part, of protein fermentation and subsequent ammonia production. Interestingly, both SCFA absorption (44) and function (eg, maintenance of mucosal barrier function) (45) may be more effective at lowering the luminal pH. Therefore, research is required to investigate whether SCFAs are effective at maintaining colonic health in patients receiving concomitant enteral feeding and antibiotics.
In conclusion, hospitalized patients receiving enteral feeding have a variable GI microbiota. Higher clostridia and lower bifidobacteria counts occur in patients who develop diarrhea, and this dysbiosis may be involved in its pathogenesis. Future research to determine whether correction of this dysbiosis reduces the incidence of diarrhea in this patient group is required.
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